stockrowPharming Group N.V. Sponsored ADR (PHAR) vs Syndax Pharmaceuticals, Inc. (SNDX)
- Pharming Group N.V. Sponsored ADR PHAR 12.32 +0.16%
- Syndax Pharmaceuticals, Inc. SNDX 9.54 +1.81%
Pharming Group N.V. Sponsored ADR and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Pharming Group N.V. Sponsored ADR and Syndax Pharmaceuticals, Inc. are of similar size ($870.6M and $843.6M). Syndax Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 34.2×. Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 159.5% against 6.76%. Pharming Group N.V. Sponsored ADR has the higher net margin (6.27% vs −72.4%) and the higher return on invested capital (10.1% vs −83.4%). Across the 18 metrics below, Pharming Group N.V. Sponsored ADR leads on 12 and Syndax Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | PHAR | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.10% | 92.21% | 68.51% |
| Operating margin | 8.40% | (61.72%) | 0.00% |
| Net margin | 6.27% | (72.38%) | 0.00% |
| Free cash flow margin | 8.92% | (61.36%) | 0.00% |
| Return on equity | 8.73% | (426.43%) | (51.96%) |
| Return on assets | 5.00% | (33.67%) | (46.06%) |
| Return on invested capital | 10.07% | (83.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack